MITROFLOW AORTIC PERICARDIAL HEART VALVE
Report
- Report Number
- 3004478276-2011-00013
- Event Type
- Other
- Date Received
- December 8, 2011
- Date of Event
- November 6, 2011
- Report Date
- December 8, 2011
- Manufacturer
- SORIN GROUP CANADA INC. MITROFLOW DIVISION
- Product Code
- LWR
- PMA / PMN Number
- P060038
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OR, US
- Reporter Occupation
- OTHER
Narratives
THE DEVICE WAS RECEIVED ON (B)(6) 2011, BUT AN EVALUATION SUMMARY IS NOT AVAILABLE AT THIS TIME. GROSS EXAMINATION INDICATED LEAFLET CALCIFICATION AND PANNUS FORMATION ON THE SEWING RING AND LEAFLETS. X-RAY ANALYSIS CONFIRMED THE PRESENCE OF CALCIFICATION. FULL MORPHO-HISTOLOGICAL ANALYSIS IS IN PROGRESS. METHOD - A REVIEW OF THE DEVICE HISTORY RECORD WAS COMPLETED. RESULT - THE RESULTS OF THE DEVICE HISTORY RECORD REVIEW CONFIRMED THE DEVICE MET ALL MATERIAL, DIMENSIONAL, AND PERFORMANCE REQUIREMENTS AT THE TIME OF MFR AND RELEASE. CONCLUSION: NO CONCLUSION CAN BE DRAWN AT THIS TIME AS DEVICE EVAL, INCLUDING HISTOPATHOLOGY, IS IN PROGRESS.
SORIN GROUP (B)(4) INC., MITROFLOW DIVISION WAS NOTIFIED ON (B)(6) 2011 OF A MITROFLOW VALVE (MODEL 12A27; S/N (B)(4)) THAT WAS EXPLANTED ON (B)(6) 2011 FOR REPORTED CENTRAL AORTIC REGURGITATION. THE VALVE WAS IMPLANTED ON (B)(6) 2004 AS PART OF THE (B)(6) STUDY. AS REPORTED, THE MITROFLOW VALVE WAS EXPLANTED AND WAS REPLACED WITH AN EDWARDS LIFESCIENCES MAGNA EASE BIOPROSTHETIC AORTIC VALVE, SIZE 29 MM. REPORTEDLY, THE PT EXPERIENCED A POST-OPERATIVE CARDIO-EMBOLIC INDUCED CVA ON (B)(6) 2011. ACCORDING TO THE FIELD EXPERIENCE REPORT FORM, THE ATTENDING SURGEON IS NOT EXPRESSING A COMPLAINT WITH THE QUALITY AND/OR PERFORMANCE OF THE MITROFLOW VALVE. THE EVENT WAS REPORTED TO THE COMPANY AS PART OF THE ONGOING MITROFLOW LONG-TERM CLINICAL STUDY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | MITROFLOW AORTIC PERICARDIAL HEART VALVE | TISSUE, HEART VALVE | LWR | SORIN GROUP CANADA INC. MITROFLOW DIVISION | 12A | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 71 YR | Required Intervention |